Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › NY › Roslyn › NPI 1043279565
Hospital

ST. Francis Hospital

ST. Francis Hospital was paid $13.48M by Medicaid between Jan 2018 and Dec 2024, across 154 billing codes. Its largest line is 99212, Office or other outpatient visit for the evaluation and management of an established patient, straightforward — 16% of everything it billed.

33Billing provider infoST. FRANCIS HOSPITAL
ROSLYN, NY 11576
33aNPI1043279565assigned 03/22/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$13.48M
24GClaims249,461
24DCodes billed154
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in New York

Rank by total paid#71 of 231
Median peer was paid$561K
This provider vs. median24×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20181,123$26K
201910,138$456K
202029,601$1.38M
202150,188$2.95M
202253,957$3.10M
202358,852$3.17M
2024incomplete45,602$2.40M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 16% 18,331 16,135 $2.16M
93458 11% 929 927 $1.55M
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 7.2% 5,425 5,341 $968K
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 6.8% 5,539 5,225 $915K
G0378 Hospital observation service, per hour 5.3% 2,703 2,619 $713K
96361 Intravenous infusion, hydration; each additional hour 4.0% 2,399 2,150 $535K
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 3.6% 2,820 2,704 $489K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress 3.2% 1,597 1,589 $437K
78431 3.0% 531 513 $407K
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 2.8% 1,928 1,864 $375K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 2.7% 2,355 1,887 $371K
G2066 Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results 2.7% 3,985 3,930 $360K
142 more codes
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 1.7% 3,274 $232K
93017 1.6% 4,542 $216K
80053 Comprehensive metabolic panel 1.6% 12,662 $214K
70450 Computed tomography, head or brain; without contrast material 1.6% 895 $212K
75574 1.5% 833 $202K
93226 1.5% 1,222 $201K
93225 1.4% 1,285 $185K
J2785 Injection, regadenoson, 0.1 mg 1.3% 1,441 $176K
99282 Emergency department visit for the evaluation and management, low to moderate severity 1.2% 802 $166K
74177 Computed tomography, abdomen and pelvis; with contrast material 1.2% 600 $159K
83880 <1% 4,588 $125K
93880 <1% 762 $122K
86850 <1% 5,460 $119K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 2,450 $107K
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose <1% 1,415 $104K
71275 Computed tomographic angiography, chest, with contrast material <1% 359 $97K
36415 Collection of venous blood by venipuncture <1% 16,249 $94K
86901 <1% 5,461 $90K
86900 <1% 5,491 $89K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 513 $85K
C9600 Percutaneous transcatheter placement of drug eluting intracoronary stent(s), with coronary angioplasty when performed; single major coronary artery or branch <1% 41 $75K
96367 <1% 753 $74K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 3,179 $64K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring <1% 204 $61K
99213 Doctor's office visit, returning patient (routine) <1% 325 $55K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward <1% 287 $41K
80061 Lipid panel <1% 4,364 $39K
0202U Oncology (prostate), multianalyte, gene expression profiling <1% 1,470 $38K
J3490 Unclassified drugs <1% 2,045 $38K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 18,111 $37K
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r <1% 535 $35K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 255 $33K
93307 <1% 180 $32K
J0248 Injection, remdesivir, 1 mg <1% 68 $31K
80048 Basic metabolic panel (calcium, ionized) <1% 1,272 $30K
85610 <1% 8,558 $29K
A9555 Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries <1% 527 $29K
M0245 Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring <1% 106 $29K
Q0247 Injection, sotrovimab, 500 mg <1% 30 $28K
C1760 Closure device, vascular (implantable/insertable) <1% 584 $27K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 978 $26K
93299 <1% 836 $22K
93970 <1% 40 $19K
85730 <1% 7,046 $17K
C1874 Stent, coated/covered, with delivery system <1% 25 $16K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 9,889 $14K
83036 Hemoglobin; glycosylated (A1C) <1% 2,244 $13K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 95 $13K
C1769 Guide wire <1% 1,060 $12K
78434 <1% 120 $12K
93296 <1% 128 $12K
71046 Radiologic examination, chest; 2 views <1% 895 $12K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 2,156 $12K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 4,447 $12K
92978 <1% 38 $10K
96375 Therapeutic injection; each additional sequential IV push <1% 2,617 $10K
M0247 Intravenous infusion, sotrovimab, includes infusion and post administration monitoring <1% 31 $10K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 49 $9K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 166 $8K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 37 $7K
84702 <1% 2,625 $7K
93298 <1% 560 $7K
99214 Doctor's office visit, returning patient (more involved) <1% 42 $7K
M0222 Intravenous injection, bebtelovimab, includes injection and post administration monitoring <1% 24 $6K
87631 <1% 118 $6K
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser <1% 891 $5K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 470 $5K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 180 $5K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 322 $4K
75561 <1% 13 $3K
M0239 Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring <1% 16 $3K
70496 <1% 13 $3K
80050 General health panel <1% 132 $3K
85027 <1% 1,611 $3K
71045 Radiologic examination, chest; single view <1% 3,364 $3K
77067 Screening mammography, bilateral, including computer-aided detection <1% 37 $3K
82947 <1% 2,639 $3K
81025 <1% 805 $3K
87581 <1% 179 $2K
87486 <1% 179 $2K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 1,963 $2K
J1756 Injection, iron sucrose, 1 mg <1% 50 $2K
81003 <1% 2,652 $2K
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 1,435 $2K
C1725 Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) <1% 26 $2K
C1887 Catheter, guiding (may include infusion/perfusion capability) <1% 170 $2K
76641 <1% 59 $2K
84443 Thyroid stimulating hormone (TSH) <1% 595 $2K
Q9957 Injection, perflutren lipid microspheres, per ml <1% 39 $1K
83735 <1% 2,212 $1K
83615 <1% 710 $1K
84484 <1% 5,085 $930.45
87088 <1% 741 $910.38
96376 <1% 228 $824.78
88342 <1% 13 $750.37
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 157 $714.16
77063 Screening digital breast tomosynthesis, bilateral <1% 37 $592.35
93320 <1% 12 $584.93
J7030 Infusion, normal saline solution , 1000 cc <1% 2,363 $475.05
J7120 Ringers lactate infusion, up to 1000 cc <1% 71 $423.15
75565 <1% 12 $420.35
72125 Computed tomography, cervical spine; without contrast material <1% 12 $394.47
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 1,544 $378.26
78492 <1% 105 $337.76
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 1,624 $328.65
S0028 Injection, famotidine, 20 mg <1% 756 $313.52
J7050 Infusion, normal saline solution, 250 cc <1% 2,517 $309.75
83605 <1% 1,598 $255.73
82977 <1% 113 $247.72
85379 <1% 1,165 $247.65
0482T <1% 72 $229.86
J2704 Injection, propofol, 10 mg <1% 1,858 $227.93
C1889 Implantable/insertable device, not otherwise classified <1% 31 $195.19
Q0239 Injection, bamlanivimab-xxxx, 700 mg <1% 15 $194.79
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 2,051 $185.64
J1170 Injection, hydromorphone, up to 4 mg <1% 549 $181.20
93325 <1% 25 $162.84
Q0243 Injection, casirivimab and imdevimab, 2400 mg <1% 19 $161.97
S0020 Injection, bupivicaine hydrochloride, 30 ml <1% 85 $156.58
83690 <1% 1,126 $127.04
J0690 Injection, cefazolin sodium, 500 mg <1% 561 $70.92
82550 <1% 37 $62.94
J3010 Injection, fentanyl citrate, 0.1 mg <1% 1,830 $50.85
84145 <1% 201 $47.26
J1644 Injection, heparin sodium, per 1000 units <1% 1,217 $40.00
87040 <1% 159 $34.30
86141 <1% 39 $20.60
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 1,360 $20.58
85651 <1% 45 $7.94
J0137 Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg <1% 243 $7.20
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg <1% 75 $6.00
J2270 Injection, morphine sulfate, up to 10 mg <1% 13 $5.73
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 91 $5.63
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 168 $1.10
J1171 Injection, hydromorphone, 0.1 mg <1% 24 $0.90
J2003 Injection, lidocaine hydrochloride, 1 mg <1% 13 $0.50
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 0% 16 $0.00
C1753 Catheter, intravascular ultrasound 0% 12 $0.00
78499 0% 36 $0.00
87428 0% 13 $0.00
J0136 Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg 0% 289 $0.00
99080 0% 267 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialARMSTRONG, WILLIAM (CHIEF FINANCIAL OFFICER)
Same official

Other billing entities under ARMSTRONG, WILLIAM

Full network →
ProviderLocationPaid
Mercy Medical CenterRockville Centre, NY$43.92M
Mercy Medical CenterRockville Centre, NY$231K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.